Porcine Circovirus Type 2 and Mycoplasma Hyopneumoniae Inactivated Vaccine (SH Strain + HN0613 Strain)

China Veterinary Drug Biological Product Approval No. :163001143

DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION:

• Intramuscular injection in the neck of pigs, the dosage is 2ml per head. Piglets are first vaccinated at age of 14 to 21 days and then repeated 2 weeks later.
• Warm the vaccine to room temperature immediately prior to administration.
• If the vaccine is discoloration, emulsification, bottle breakage, mixed foreign matter, etc., Do Not Use.
• Use entire contents on the day when first opened

Feature

Initiate in China with fully independent R&D

Best Selling Products in this segment market in China

Antigen purification without interference and no compatibility concern

• By optimizing the medium parameters and fermentation parameters, we have broken through the problem of low generation and high-density fermentation process of mycoplasma
• Completely removed the residual circulating antibody in the serum for mycoplasma culture by tangential flow ultrafiltration + protein multiuser dispersion+other purification processes
• Avoiding interference with circulating virus immunity and solving the compatibility problem of circulating and mycoplasma antigens
• CCU level of 700L fermentation can reach up to 1×1010CCU/mL
• 8 times higher than that of commercially available vaccine-content of mycoplasma in vaccine is ≥4×10^9.0CCU/head
• Cultivated antigen with PK-B1 susceptible clone cells line can boost the Porcine circovirus type 2 content in the vaccine ≥1.0×10^7.0TCID₅₀ /head.

Patented Aquae adjuvant Freemix^TM for simultaneous application of dual antigens

This vaccine is accompanied by an internationally advanced aquae adjuvant Freemix^TM which is prepared by colloidal polymer cross-linked copolymer into nano-microspheres with a spatial reticulation structure inside the microspheres, which has high efficiency in adsorbing antigens, thus realizing long-lasting and slow release, and can efficiently recruit immune cells.

Contains innovative Freemix^TM adjuvant technology that provide easy vaccine absorption, raid onset of immunity-7 days post immunization as well as <0.01% adverse reaction in pigs. Provide at least 24 weeks of immunity to last through market

8 effectiveness proved with customs

• Reduce the use of antibiotics by 10%-20%
• Post-immunization stress reduction by 2-3 times
• Reduce the incidence of respiratory diseases by 20%
• Decrease labor intensity
• Improve daily weight gain by 30-70g
• Improve herd uniformity by 20%.
• Increase survival rate by 2-4%,
• Increase efficiency